David D. O'Toole - 18 Feb 2026 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
CFO
Signature
David O'Toole
Issuer symbol
RCEL
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 16:38:20 UTC
Previous filing
26 Aug 2025
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
O'Toole David D CFO 28159 AVENUE STANFORD, SUITE 220 - AVITA MEDICAL, VALENCIA David O'Toole 19 Feb 2026 0001491140

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +105,470 +333% 137,127 18 Feb 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +155,510 $0.000000 155,510 18 Feb 2026 Common Stock 155,510 $4.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026.
F2 Includes unvested RSUs.
F3 These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026.